Witness Signup

Name	Organization	Position	Testimony	Committee
Senator Gile, Senator Gile		FAV	In Person - Oral Testimony	FIN
Rosen-Cohen, Nancy	NCADD-Maryland	FAV	NCADD-MD - 2026 SB 562 FAV - Prescriber-Pharmacist	FIN
Ciekot, Ann	Public Policy Partners	FAV	In Person - Oral Testimony	FIN
Brocato, Deborah		UNF	No Testimony	FIN
Kennedy, Anita	National Alliance of Medication Assisted Recovery, Inc.	FAV	testimony SB 562 pharmacist agreements MOUD MDDCSA	FIN
Melvin, Robert	R Street Institute	FAV	FINAL 2026 MD SB 562 Testimony - Stacey McKenna.pd	FIN
York, Katie		FAV	No Testimony	FIN
Ebron, Jasmine		FAV	In Person - Oral Testimony	FIN
(MD), State of Maryland		INFO	SB 562 - FIN - BOP - LOI.docx.pdf	FIN
Rabbitt, Dan	Behavioral Health System Baltimore	FAV	SB 562_MOUD Pharmacist Agreements_BHSB_FAVORABLE.p	FIN
State of, Maryland		FAV	SB 562 - FIN - BoPHARM - LOS.pdf	FIN
Tibbals, Trudy		UNF	SB 562_HB 838_ State Board of Pharmacy - Prescrib	FIN
Wise, Steve		FAV	SB0562_FAV_MedChi_State Board Pharmacy - Prescribe	FIN
Horton, Aliyah	Maryland Pharmacists Association	FAV	In Person - Oral Testimony SB562.Prescriber-Pharmacist Agreements.MPhA.pdf	FIN
Keller, Emily	Maryland's Office of Overdose Response	FAV	In Person - Oral Testimony WrittenTestimony-SB562 - MOOR - LOS.docx.pdf	FIN
Shimoda, Matthew	Maryland Board of Pharmacy	FAV	In Person - Oral Testimony	FIN
Elliott, Robyn		FWA	In Person - Oral Testimony 2026 ACNM SB 562 Senate Side.pdf	FIN
Partners, Public Policy		FAV	2026 MCHS SB 562 Senate Side.pdf	FIN
Bogley, Laura	Maryland Right to Life	UNF	UNFAVORABLE.SB562.HB838.MDRTL.LauraBogley.pdf	FIN
dipaula, Bethany		FAV	Virtual - Oral Testimony	FIN
Gile, Dawn	MD Senate	FAV	SB 562 Written Testimony - Sen. Gile.docx.pdf SB562_Amendment_693923 SB562_FinalReprint_693923	FIN
Testimony, All		N/A	Merged Testimony as of 3-3-2026 at 1211 PM	FIN

Committee Testimony and Witness Signup

SB0562 - State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

Finance 3/3/2026 1:00:00 PM